The Uro-Bionic Therapeutics Lab builds machines small enough to swim to a tumor. We combine magnetic microrobotics, shape-shifting nanomedicine, and cancer immunotherapy to deliver treatment precisely where bladder and other urologic cancers hide, actively steering our carriers to the target instead of relying on passive diffusion, and acting locally to spare the rest of the body.

Lab director Dr. Zhaoqing Cong earned his Ph.D. in Pharmaceutics from Peking Union Medical College and completed postdoctoral training in Biochemistry and Molecular Medicine at the University of California, Davis. Explore the three platforms we're building on our Research Focus page.